NeuroPace, Inc.
NPCE
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remā¦ read more
Healthcare
Medical Devices
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$14.40
Price+0.84%
$0.12
1Y
Price
Market Cap
$490.950m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-21.1%
EBITDA Margin-30.3%
Net Profit Margin-27.3%
Free Cash Flow Margin-21.1%
EBITDA Margin-30.3%
Net Profit Margin-27.3%
Free Cash Flow MarginRevenue
$99.530m
-0.5%
1y CAGR+15.6%
3y CAGR+22.6%
5y CAGREarnings
-$21.565m
-0.5%
1y CAGR+12.7%
3y CAGR+17.0%
5y CAGREPS
-$0.65
+1.5%
1y CAGR+19.1%
3y CAGR+22.7%
5y CAGRBook Value
$14.454m
$98.898m
Assets$84.444m
Liabilities$70.462m
DebtDebt to Assets
71.3%
-5.1x
Debt to EBITDAFree Cash Flow
-$9.836m
+13.3%
1y CAGR+19.8%
3y CAGR+26.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company